Borosil Scientific (BOROSCI) — Annual Report

📢 Key Event
35th AGM scheduled for September 25, 2026, to approve FY2025-26 financials and director reappointments

🔄 What Changed
Consolidated PAT grew 29.41% to ₹3,458.12 lakhs; revenue rose 6.58% to ₹46,734.15 lakhs; no dividend recommended

🔮 What's Next
Board recommends approving ₹250 crores fund raise via securities; ESOP scheme amendments for trust-based administration

💡 Investor Takeaway
Strong PAT growth and revenue expansion signal healthy financial momentum, but no dividends will be paid to retain capital for strategic investments.

Borosil Scientific Ltd's FY 2025-26 Annual Report details its 35th AGM scheduled for September 25, 2026, where shareholders will approve the audited financial statements, re-appoint directors including CEO Vinayak Patankar, and authorize related party transactions with Borosil Limited. The report highlights consolidated revenue of ₹46,734.15 lakhs and PAT of ₹3,458.12 lakhs, reflecting 29.41% growth, alongside strategic expansion in lab consumables, instrumentation, and pharmaceutical packaging. Key risks include input cost volatility and import dependency, mitigated through supplier diversification and backward integration. The company emphasizes ESG commitments, with 5% annual electricity reduction and 3% GHG emissions cut, while maintaining strong liquidity and no dividend payouts to conserve capital. Governance disclosures confirm compliance with SEBI regulations, robust internal controls, and independent auditor certifications, reinforcing transparency for shareholders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BOROSCI ✨ Ask AI About This

About Borosil Scientific Ltd (BOROSCI)

Construction Materials · Glass & Glass Products · Listed on BSE

Market Cap: ₹1,128.29 Cr P/E: 26.1 ROE: 10.7% ROCE: 12.9%

View full BOROSCI stock details →

📡 Get AI alerts when BOROSCI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BOROSCI — Free

💡 Ask AI about this filing

"How will the ₹250 crore fund raise be utilized for capex and working capital?" "What is the expected timeline for ESOP scheme implementation via the trust route?" "How does the company plan to mitigate input cost volatility in raw material procurement?"

Ask AI Free →

📊 More BOROSCI filings

See all BOROSCI filings →

🔥 Also filed on 1 September 2026

544083 Shree Marutinandan Tubes Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement FORTIS Fortis Healthcare Ltd Announcement JNPR Juniper Green Energy Ltd Announcement SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BOROSCI files new disclosures

Track BOROSCI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BOROSCI — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd